181 related articles for article (PubMed ID: 22858519)
1. Development of pylomatrixoma after the subcutaneous injection of methotrexate for the treatment of juvenile idiopathic arthritis.
Afonso Pérez E; Garcia Porrua C; Castiñeiras Mato IM; Bal Nieves F
Reumatol Clin; 2012; 8(6):380-1. PubMed ID: 22858519
[No Abstract] [Full Text] [Related]
2. Decreased expression of nicotinamide phosphoribosyltransferase in patients with juvenile idiopathic arthritis receiving methotrexate.
Fox EJ; Leeder JS; Ye SQ; Becker ML
J Rheumatol; 2013 May; 40(5):741-2. PubMed ID: 23637381
[No Abstract] [Full Text] [Related]
3. Glucocorticoids in juvenile idiopathic arthritis.
Malattia C; Martini A
Ann N Y Acad Sci; 2014 May; 1318():65-70. PubMed ID: 24738483
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate: new uses for an old drug.
Hashkes PJ; Becker ML; Cabral DA; Laxer RM; Paller AS; Rabinovich CE; Turner D; Zulian F
J Pediatr; 2014 Feb; 164(2):231-6. PubMed ID: 24286573
[No Abstract] [Full Text] [Related]
5. Juvenile idiopathic arthritis in the new world of biologics.
Ostring GT; Singh-Grewal D
J Paediatr Child Health; 2013 Sep; 49(9):E405-12. PubMed ID: 23647810
[TBL] [Abstract][Full Text] [Related]
6. Juvenile idiopathic arthritis: updated guide to administering methotrexate.
Livermore P
Nurs Child Young People; 2014 Feb; 26(1):26-9. PubMed ID: 24517621
[TBL] [Abstract][Full Text] [Related]
7. Combining cyclosporine with prevailing antirheumatic drug therapy in the treatment of juvenile idiopathic arthritis.
Haapasaari J; Kautiainen H; Hakala M
Clin Exp Rheumatol; 2002; 20(2):259. PubMed ID: 12051414
[No Abstract] [Full Text] [Related]
8. Children with juvenile idiopathic arthritis frequently experience interruptions to their medical therapy.
Kazamia K; Holmquist L; Fagerlund A; Berntson L
Acta Paediatr; 2014 May; 103(5):529-36. PubMed ID: 24517256
[TBL] [Abstract][Full Text] [Related]
9. On beyond methotrexate treatment of severe juvenile rheumatoid arthritis.
Wallace CA
Clin Exp Rheumatol; 1999; 17(4):499-504. PubMed ID: 10464566
[No Abstract] [Full Text] [Related]
10. Genetic variants influencing response to methotrexate in juvenile idiopathic arthritis and rheumatoid arthritis.
Ranganathan P
Rheumatol Int; 2016 Jan; 36(1):53-4. PubMed ID: 26156235
[No Abstract] [Full Text] [Related]
11. Life-threatening pneumonitis complicating low-dose methotrexate treatment for juvenile idiopathic arthritis in a child.
Liu YC; Tu YL; Wu RC; Huang JL; Yao TC
Pediatr Emerg Care; 2014 Jun; 30(6):415-7. PubMed ID: 24892681
[TBL] [Abstract][Full Text] [Related]
12. Prefilled pen versus prefilled syringe: a pilot study evaluating two different methods of methotrexate subcutaneous injection in patients with JIA.
Roszkiewicz J; Swacha Z; Smolewska E
Pediatr Rheumatol Online J; 2020 Aug; 18(1):64. PubMed ID: 32787934
[TBL] [Abstract][Full Text] [Related]
13. Eosinophilia as a side-effect of methotrexate in patients with chronic arthritis.
Savolainen HA; Leirisalo-Repo M
Clin Rheumatol; 2001; 20(6):432-4. PubMed ID: 11771529
[TBL] [Abstract][Full Text] [Related]
14. The value of old drugs for juvenile idiopathic arthritis.
Wulffraat N
Lancet; 2017 Mar; 389(10072):883-884. PubMed ID: 28162780
[No Abstract] [Full Text] [Related]
15. Trends in medication usage in juvenile idiopathic arthritis: prescribing trends or trends in prescribers?
Levy D
J Rheumatol; 2014 Oct; 41(10):1903-5. PubMed ID: 25275091
[No Abstract] [Full Text] [Related]
16. Radiologic progression in patients with juvenile chronic arthritis treated with methotrexate.
Ravelli A; Viola S; Ramenghi B; Beluffi G; Zonta LA; Martini A
J Pediatr; 1998 Aug; 133(2):262-5. PubMed ID: 9709717
[TBL] [Abstract][Full Text] [Related]
17. Strategies for the prevention and management of methotrexate-related nausea and vomiting in juvenile idiopathic arthritis: results of a UK Paediatric Rheumatology prescriber survey.
Amin TS; Shenton S; Mulligan K; Wedderburn LR; Wood M; VanRooyen V; Leone V
Rheumatology (Oxford); 2015 Nov; 54(11):2108-9. PubMed ID: 26209331
[No Abstract] [Full Text] [Related]
18. Macrophage activation syndrome as the initial manifestation of systemic onset juvenile idiopathic arthritis.
Cuende E; Vesga JC; Pérez LB; Ardanaz MT; Guinea J
Clin Exp Rheumatol; 2001; 19(6):764-5. PubMed ID: 11791663
[No Abstract] [Full Text] [Related]
19. British isles survey of methotrexate monitoring practice during treatment of juvenile idiopathic arthritis.
Hawley DP; Camina N; Rangaraj S
Semin Arthritis Rheum; 2011 Feb; 40(4):358-64.e1-2. PubMed ID: 20822799
[TBL] [Abstract][Full Text] [Related]
20. Novel treatment options for juvenile idiopathic arthritis.
Steigerwald KA; Ilowite NT
Expert Rev Clin Pharmacol; 2015; 8(5):559-73. PubMed ID: 26294075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
